Hematology News

The incidence of cardiac amyloidosis in the Danish population increased in the last 2 decades, translating to a potential increase in the global population, according to research published in JACC: CardioOncology.

Patients with VEXAS syndrome who were blood transfusion dependent or had a variant of the valine gene exhibited a threefold increased risk for mortality, according to data presented at ACR Convergence 2021.

In a recent population-based cohort study, researchers observed an increased risk for cerebral venous sinus thrombosis after administration of the Johnson & Johnson COVID-19 vaccine.

Very low-birth-weight infants who received blood transfusions from female donors had a lower risk for mortality and/or serious morbidity than those who received transfusions from male donors, study results showed.

Three individuals have been elected to American Society of Hematology’s executive committee.

Therapeutic-dose low-molecular-weight heparin decreased the likelihood of blood clots and death compared with standard of care among patients hospitalized with COVID-19, according to study results published in JAMA Internal Medicine.

New guidelines for sickle cell disease issued by ASH and published in Blood Advances aim to inform practitioners and patients on use of hematopoietic stem cell transplantation in clinical practice.

The CRISPR/Cas9 gene-editing system already is producing results that may fundamentally transform the treatment of certain diseases, according to one of the recipients of the 2020 Nobel Prize in Chemistry.

World Thrombosis Day is observed Oct. 13.

Rivaroxaban appeared associated with a higher rate of gastrointestinal bleeding than other direct oral anticoagulants, according to study results published in Annals of Internal Medicine.